Sophia Genetic…
ProfileJobs

Sophia Genetics

Suggest Edit
    • HealthTechnologyanalyticsartificial intelligencemedical diagnostics

    Sophia Genetics is a health technology company which develops SOPHiA artificial intelligence for clinical genomics used by healthcare institutions worldwide. The Company offers DRY LAB, an analytical solution for treating raw next-generation DNA sequencing (NGS) data; BUNDLE that offers enrichment kit and access to SOPHiA DDM platform; and integrated diagnostic solutions. It also provides SOPHiA DDM, a software-as-a-service platform that enables analysis and protection of clinical NGS data in the areas of oncology, metabolism, pediatrics, cardiology, and hereditary cancer.

    Total Funding
    $58.8 M
    Type
    Private
    HQ
    Saint-Sulpice, CH
    Founded
    2011
    Size (employees)
    182 (est)+4%
    Website
    sophiagenetics.com
    Sophia Genetics was founded in 2011 and is headquartered in Saint-Sulpice, CH
    Report incorrect company information

    Key People/Management at Sophia Genetics

    Jurgi Camblong

    Jurgi Camblong

    Chief Executive Officer and Co-Founder
    Valentin Matillon

    Valentin Matillon

    CFO
    Damien Lapray

    Damien Lapray

    Chief Commercial Officer
    Marylin Schule

    Marylin Schule

    Chief Operations Officer
    Didier Pitton

    Didier Pitton

    Chief Product Officer
    Jasmine Beukema

    Jasmine Beukema

    VP Quality
    Show more

    Sophia Genetics Office Locations

    Sophia Genetics has offices in Saint-Sulpice, Cambridgeshire and Montpellier
    Saint-Sulpice, CH (HQ)
    172 Rue du Centre
    Montpellier, FR
    55 Impasse Mac Gaffey
    Cambridgeshire, GB
    Cowley Rd
    Show all (3)
    Report incorrect company information

    Sophia Genetics Financials and Metrics

    Summary Metrics

    Founding Date

    		2011

    Total Funding

    		$58.8 m

    Latest funding size

    		$30 m

    Time since last funding

    		9 months ago

    Investors

    		360 Capital Partners, Invoke Capital Partners, Marc Coucke, Balderton Capital, Alychlo
    Sophia Genetics's latest funding round in September 2017 was reported to be $30 m. In total, Sophia Genetics has raised $58.8 m
    Show all financial metrics
    Report incorrect company information

    Competitors

    Ultromics
    Health - Private
    Curai
    Health - Private
    Ventana Medical Systems
    Health - Subsidiary
    Semantix
    Health - Private
    Compare competitors

    Sophia Genetics Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Sophia Genetics News and Updates

    September 13, 2017

    Swiss health tech company Sophia Genetics lands $30 mln Series D

    Sophia Genetics, a Swiss health tech company, has secured $30 million in Series D funding. Balderton Capital led the round with participation from 360º Capital Partners, Invoke Capital and Alychlo.
    Report incorrect company information
    Download PDF